[1]
Psychopharmacological treatment of Obsessive-Compulsive Disorder (OCD)., Casale AD,Sorice S,Padovano A,Simmaco M,Ferracuti S,Lamis DA,Rapinesi C,Sani G,Girardi P,Kotzalidis GD,Pompili M,, Current neuropharmacology, 2018 Aug 13 [PubMed PMID: 30101713]
[2]
Hollander E,Kaplan A,Allen A,Cartwright C, Pharmacotherapy for obsessive-compulsive disorder. The Psychiatric clinics of North America. 2000 Sep; [PubMed PMID: 10986733]
[3]
Eddy KT,Dutra L,Bradley R,Westen D, A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder. Clinical psychology review. 2004 Dec; [PubMed PMID: 15533282]
[4]
Greist JH,Jefferson JW,Kobak KA,Katzelnick DJ,Serlin RC, Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. Archives of general psychiatry. 1995 Jan; [PubMed PMID: 7811162]
[5]
Meyer JH,Wilson AA,Ginovart N,Goulding V,Hussey D,Hood K,Houle S, Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. The American journal of psychiatry. 2001 Nov; [PubMed PMID: 11691690]
[6]
Montgomery SA,Baldwin DS,Blier P,Fineberg NA,Kasper S,Lader M,Lam RW,Lépine JP,Möller HJ,Nutt DJ,Rouillon F,Schatzberg AF,Thase ME, Which antidepressants have demonstrated superior efficacy? A review of the evidence. International clinical psychopharmacology. 2007 Nov; [PubMed PMID: 17917550]
[7]
Hollander E,Allen A,Kwon J,Aronowitz B,Schmeidler J,Wong C,Simeon D, Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Archives of general psychiatry. 1999 Nov; [PubMed PMID: 10565503]
[8]
Palmer NR,Stuckey BG, Premature ejaculation: a clinical update. The Medical journal of Australia. 2008 Jun 2; [PubMed PMID: 18513177]
[9]
Caldwell PH,Sureshkumar P,Wong WC, Tricyclic and related drugs for nocturnal enuresis in children. The Cochrane database of systematic reviews. 2016 Jan 20; [PubMed PMID: 26789925]
[10]
Rothbart R,Amos T,Siegfried N,Ipser JC,Fineberg N,Chamberlain SR,Stein DJ, Pharmacotherapy for trichotillomania. The Cochrane database of systematic reviews. 2013 Nov 8; [PubMed PMID: 24214100]
[11]
Franklin ME,Zagrabbe K,Benavides KL, Trichotillomania and its treatment: a review and recommendations. Expert review of neurotherapeutics. 2011 Aug; [PubMed PMID: 21797657]
[13]
Suhara T,Takano A,Sudo Y,Ichimiya T,Inoue M,Yasuno F,Ikoma Y,Okubo Y, High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography. Archives of general psychiatry. 2003 Apr; [PubMed PMID: 12695316]
[14]
Pallanti S,Hollander E,Bienstock C,Koran L,Leckman J,Marazziti D,Pato M,Stein D,Zohar J, Treatment non-response in OCD: methodological issues and operational definitions. The international journal of neuropsychopharmacology. 2002 Jun; [PubMed PMID: 12135542]
[15]
Warneke LB, The use of intravenous chlorimipramine in the treatment of obsessive compulsive disorder. Canadian journal of psychiatry. Revue canadienne de psychiatrie. 1984 Mar; [PubMed PMID: 6722705]
[16]
Warneke L, Intravenous chlorimipramine therapy in obsessive-compulsive disorder. Canadian journal of psychiatry. Revue canadienne de psychiatrie. 1989 Dec; [PubMed PMID: 2611753]
[17]
Bloch MH,Green C,Kichuk SA,Dombrowski PA,Wasylink S,Billingslea E,Landeros-Weisenberger A,Kelmendi B,Goodman WK,Leckman JF,Coric V,Pittenger C, Long-term outcome in adults with obsessive-compulsive disorder. Depression and anxiety. 2013 Aug; [PubMed PMID: 23532944]
[18]
Dold M,Aigner M,Lanzenberger R,Kasper S, Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials. The international journal of neuropsychopharmacology. 2013 Apr; [PubMed PMID: 22932229]
[19]
Källén B,Otterblad Olausson P, Antidepressant drugs during pregnancy and infant congenital heart defect. Reproductive toxicology (Elmsford, N.Y.). 2006 Apr; [PubMed PMID: 16406480]
[20]
Bloem BR,Lammers GJ,Roofthooft DW,De Beaufort AJ,Brouwer OF, Clomipramine withdrawal in newborns. Archives of disease in childhood. Fetal and neonatal edition. 1999 Jul; [PubMed PMID: 10744432]
[22]
Bertilsson L,Dahl ML,Dalén P,Al-Shurbaji A, Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. British journal of clinical pharmacology. 2002 Feb; [PubMed PMID: 11851634]